144 related articles for article (PubMed ID: 17410286)
21. Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B.
Sebastiani G; Vario A; Guido M; Alberti A
World J Gastroenterol; 2007 Jan; 13(4):525-31. PubMed ID: 17278217
[TBL] [Abstract][Full Text] [Related]
22. Validation of hepascore, compared with simple indices of fibrosis, in patients with chronic hepatitis C virus infection in United States.
Becker L; Salameh W; Sferruzza A; Zhang K; ng Chen R; Malik R; Reitz R; Nasser I; Afdhal NH
Clin Gastroenterol Hepatol; 2009 Jun; 7(6):696-701. PubMed ID: 19514117
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic value of combined serum biomarkers for the evaluation of liver fibrosis in chronic hepatitis C infection: A multicenter, noninterventional, observational study.
Köksal İ; Yılmaz G; Parlak M; Demirdal T; Kınıklı S; Candan M; Kaya A; Akhan S; Aydoğdu Ö; Turgut H; Gürbüz Y; Dağlı Ö; Gökal AA; Güner R; Kuruüzüm Z; Tarakçı H; Beslen N; Erdoğan S; Özdener F; Study Group TCHC
Turk J Gastroenterol; 2018 Jul; 29(4):464-472. PubMed ID: 30249562
[TBL] [Abstract][Full Text] [Related]
24. Usefulness of non-invasive markers for predicting liver cirrhosis in patients with chronic hepatitis B.
Lee KG; Seo YS; An H; Um SH; Jung ES; Keum B; Yim HJ; Jeen YT; Chun HJ; Kim CD; Ryu HS
J Gastroenterol Hepatol; 2010 Jan; 25(1):94-100. PubMed ID: 19793171
[TBL] [Abstract][Full Text] [Related]
25. Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B.
Myers RP; Tainturier MH; Ratziu V; Piton A; Thibault V; Imbert-Bismut F; Messous D; Charlotte F; Di Martino V; Benhamou Y; Poynard T
J Hepatol; 2003 Aug; 39(2):222-30. PubMed ID: 12873819
[TBL] [Abstract][Full Text] [Related]
26. Optimal correlation between different instruments for Fibrotest-Actitest protein measurement in patients with chronic hepatitis C.
Rosenthal-Allieri MA; Tran A; Halfon P; Imbert-Bismut F; Munteanu M; Messous D; Peritore ML; Poynard T; Bernard A
Gastroenterol Clin Biol; 2007 Oct; 31(10):815-21. PubMed ID: 18166859
[TBL] [Abstract][Full Text] [Related]
27. Simple biochemical parameters and a novel score correlate with absence of fibrosis in patients with nonalcoholic fatty liver disease.
Shukla A; Kapileswar S; Gogtay N; Joshi A; Dhore P; Shah C; Abraham P; Bhatia S
Indian J Gastroenterol; 2015 Jul; 34(4):281-5. PubMed ID: 26341864
[TBL] [Abstract][Full Text] [Related]
28. Evaluating Diagnostic Accuracy of Noninvasive Tests in Assessment of Significant Liver Fibrosis in Chronic Hepatitis C Egyptian Patients.
Omran D; Zayed RA; Nabeel MM; Mobarak L; Zakaria Z; Farid A; Hassany M; Saif S; Mostafa M; Saad OK; Yosry A
Viral Immunol; 2018 May; 31(4):315-320. PubMed ID: 29630460
[TBL] [Abstract][Full Text] [Related]
29. Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca study.
Halfon P; Bourliere M; Deydier R; Botta-Fridlund D; Renou C; Tran A; Portal I; Allemand I; Bertrand JJ; Rosenthal-Allieri A; Rotily M; Sattonet C; Benderitter T; Saint Paul MC; Bonnot HP; Penaranda G; Degott C; Masseyeff MF; Ouzan D
Am J Gastroenterol; 2006 Mar; 101(3):547-55. PubMed ID: 16542291
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic value of serum protein profiling by SELDI-TOF ProteinChip compared with a biochemical marker, FibroTest, for the diagnosis of advanced fibrosis in patients with chronic hepatitis C.
Morra R; Munteanu M; Bedossa P; Dargere D; Janneau JL; Paradis V; Ratziu V; Charlotte F; Thibault V; Imbert-Bismut F; Poynard T
Aliment Pharmacol Ther; 2007 Sep; 26(6):847-58. PubMed ID: 17767469
[TBL] [Abstract][Full Text] [Related]
31. Discordance between liver biopsy and FibroTest in assessing liver fibrosis in chronic hepatitis B.
Park MS; Kim BK; Cheong JY; Kim DJ; Park JY; Kim DY; Ahn SH; Han KH; Chon CY; Kim SU
PLoS One; 2013; 8(2):e55759. PubMed ID: 23405210
[TBL] [Abstract][Full Text] [Related]
32. Noninvasive biomarkers FibroTest and ActiTest versus liver biopsy in chronic hepatitis C patients: the Middle East experience.
Yakoob R; Bozom IA; Thandassery RB; Rahman MO; Derbala MF; Mohannadi MJ; John AK; Sharma M; Wani H; Kaabi SA
Ann Gastroenterol; 2015; 28(2):265-270. PubMed ID: 25830472
[TBL] [Abstract][Full Text] [Related]
33. Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C.
Lewin M; Poujol-Robert A; Boëlle PY; Wendum D; Lasnier E; Viallon M; Guéchot J; Hoeffel C; Arrivé L; Tubiana JM; Poupon R
Hepatology; 2007 Sep; 46(3):658-65. PubMed ID: 17663420
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic accuracy of the Coopscore
Taibi L; Boyd A; Bosselut N; Bottero J; Guéchot J; Lacombe K; Lasnier E; Baudin B; Vaubourdolle M
Ann Clin Biochem; 2018 Mar; 55(2):236-243. PubMed ID: 28661201
[TBL] [Abstract][Full Text] [Related]
35. [Evaluation of non-invasive fibrosis indices in Mexican patients with chronic hepatitis C].
Ortiz-Olvera NX; Herrera-Chi BA; Méndez-Navarro J; Morán-Villota S; Dehesa-Violante M
Rev Gastroenterol Mex; 2010; 75(4):389-95. PubMed ID: 21169105
[TBL] [Abstract][Full Text] [Related]
36. FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy.
Shaheen AA; Wan AF; Myers RP
Am J Gastroenterol; 2007 Nov; 102(11):2589-600. PubMed ID: 17850410
[TBL] [Abstract][Full Text] [Related]
37. Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis.
Friedrich-Rust M; Rosenberg W; Parkes J; Herrmann E; Zeuzem S; Sarrazin C
BMC Gastroenterol; 2010 Sep; 10():103. PubMed ID: 20828377
[TBL] [Abstract][Full Text] [Related]
38. Comparison of non-invasive assessment to diagnose liver fibrosis in chronic hepatitis B and C patients.
Stibbe KJ; Verveer C; Francke J; Hansen BE; Zondervan PE; Kuipers EJ; de Knegt RJ; van Vuuren AJ
Scand J Gastroenterol; 2011 Jul; 46(7-8):962-72. PubMed ID: 21623677
[TBL] [Abstract][Full Text] [Related]
39. Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C.
Halfon P; Bacq Y; De Muret A; Penaranda G; Bourliere M; Ouzan D; Tran A; Botta D; Renou C; Bréchot MC; Degott C; Paradis V
J Hepatol; 2007 Mar; 46(3):395-402. PubMed ID: 17156890
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients.
Patel K; Gordon SC; Jacobson I; Hézode C; Oh E; Smith KM; Pawlotsky JM; McHutchison JG
J Hepatol; 2004 Dec; 41(6):935-42. PubMed ID: 15582126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
